Executive Director, U.S. HCP Marketing
Madrigal Pharmaceuticals · Waltham, MA · 1 mo ago
Business Development$300k–$345k/yrFull-time
About the role
Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). Its medication Rezdiffra (resmetirom) is the first and only FDA‑ and European Commission‑approved treatment for MASH with moderate to advanced fibrosis (F2‑F3). The Executive Director, U.S. HCP Marketing for Rezdiffra will shape and execute the HCP marketing strategy for Rezdiffra and the broader MASH therapeutic category, leading all HCP‑facing marketing efforts, partnering cross‑functionally, and driving brand growth in a fast‑growing, high‑visibility launch environment.
Responsibilities
- Strategic Leadership: Own the HCP marketing strategy and contribute to the annual global brand plan for Rezdiffra, aligning tactics to lifecycle stage, competitive dynamics, and portfolio priorities; translate market research, prescriber analytics, and customer feedback into differentiated brand positioning and messaging for HCP audiences; anticipate and plan for competitive threats and adjust HCP strategy accordingly.
- Campaign & Content Development: Lead development of core and derivative promotional tools, evolve promotional claims beyond label using FDA’s CFL guidance; oversee non‑personal promotion (NPP) strategy across peer‑to‑peer channels, paid media, and programmatic/digital channels targeting HCPs; ensure all materials are scientifically accurate, on‑label, and approved through the Promotional Review Committee (PRC).
- KOL & Congress Strategy: Develop and manage KOL engagement strategy with Thought Leader Liaison, Medical Affairs, and Sales, overseeing advisory boards and promotional speaker bureau; own planning and execution for major medical congresses and conferences (booth strategy, product theaters, print and digital sponsorships).
- Sales Enablement: Serve as primary marketing partner to Sales Leadership, ensuring field teams receive compelling, compliant tools and messaging; partner with Commercial training for implementation of